Plasma concentration of brominated flame retardants and postmenopausal breast cancer risk: a nested case-control study in the French E3N cohort

Table 3 Spearman rank correlation coefficients between PBDE and PBB-153 plasma concentrations (ng/L plasma and ng/gr lipids), E3N cohort

	PBDE28 (ng/L plasma)	PBDE28 (ng/gr lipids)	PBDE47 (ng/L plasma)	PBDE47 (ng/gr lipids)	PBDE99 (ng/L plasma)	PBDE99 (ng/gr lipids)	PBDE100 (ng/L plasma)	PBDE100 (ng/gr lipids)	PBDE153 (ng/L plasma)	PBDE153 (ng/gr lipids)	PBDE154 (ng/L plasma)	PBDE154 (ng/gr lipids)	PBB153 (ng/L plasma)	PBB153 (ng/gr lipids)
PBDE28 (ng/L plasma)	1.00
PBDE28 (ng/gr lipids)	0.97	1.00
PBDE47 (ng/L plasma)	0.66	0.62	1.00
PBDE47 (ng/gr lipids)	0.63	0.66	0.96	1.00
PBDE99 (ng/L plasma)	0.55	0.51	0.87	0.83	1.00
PBDE99 (ng/gr lipids)	0.53	0.55	0.84	0.87	0.96	1.00
PBDE100 (ng/L plasma)	0.63	0.59	0.92	0.87	0.81	0.76	1.00
PBDE100 (ng/gr lipids)	0.61	0.62	0.90	0.92	0.78	0.80	0.96	1.00
PBDE153 (ng/L plasma)	0.32	0.28	0.46	0.41	0.42	0.37	0.51	0.47	1.00
PBDE153 (ng/gr lipids)	0.27	0.32	0.39	0.45	0.35	0.40	0.43	0.50	0.90	1.00
PBDE154 (ng/L plasma)	0.48	0.45	0.69	0.66	0.62	0.60	0.73	0.71	0.40	0.35	1.00
PBDE154 (ng/gr lipids)	0.45	0.47	0.65	0.68	0.59	0.62	0.69	0.72	0.36	0.39	0.97	1.00
PBB153 (ng/L plasma)	0.05	−0.01	0.12	0.06	0.07	0.01	0.19	0.14	0.48	0.39	0.14	0.09	1.00
PBB153 (ng/gr lipids)	0.00	0.03	0.06	0.09	0.02	0.04	0.13	0.17	0.43	0.49	0.09	0.12	0.93	1.00

ISSN: 1476-069X